MENU
+Compare
TRAW
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$5.43
Change
+$0.10 (+1.88%)
Capitalization
15.19M

TRAW Traws Pharma Inc Forecast, Technical & Fundamental Analysis

a company which engages in the identification and development of oncology therapeutics

Industry Biotechnology
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for TRAW with price predictions
Dec 20, 2024

TRAW in -7.18% downward trend, falling for three consecutive days on December 13, 2024

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TRAW declined for three days, in of 346 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 33 cases where TRAW's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

TRAW broke above its upper Bollinger Band on December 18, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TRAW's RSI Oscillator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 18, 2024. You may want to consider a long position or call options on TRAW as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TRAW just turned positive on December 02, 2024. Looking at past instances where TRAW's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

TRAW moved above its 50-day moving average on December 17, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TRAW crossed bullishly above the 50-day moving average on December 19, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRAW advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 103 cases where TRAW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.616) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). TRAW has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (22.075) is also within normal values, averaging (256.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TRAW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRAW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company which engages in the identification and development of oncology therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12 Penns Trail
Phone
+1 267 759-3680
Employees
17
Web
https://www.onconova.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RWT6.770.13
+1.96%
Redwood Trust
ATO139.691.72
+1.25%
Atmos Energy Corp
CTGO10.300.06
+0.59%
Contango ORE
VRME0.63N/A
-0.11%
VerifyMe
YETI39.41-0.22
-0.56%
YETI Holdings

TRAW and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with MDGL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-5.90%
MDGL - TRAW
39%
Loosely correlated
+5.12%
CYTK - TRAW
36%
Loosely correlated
+4.56%
ORMP - TRAW
34%
Loosely correlated
-4.82%
SNPX - TRAW
32%
Poorly correlated
+19.69%
AXON - TRAW
32%
Poorly correlated
+2.60%
More